Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Hypogonadal Males: early-phase trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Hypogonadal Males: 2 US clinical trials tracked, none currently recruiting.

Hypogonadal Males is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott, running 1 of these trials.

Enrollment posture brief

Registry condition hypogonadal-males

OPEN 0 | RECR 0% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Hypogonadal Males (this)0%
Open-enrollment share among volume-matched conditions near Hypogonadal Males

Hypogonadal Males has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hypogonadal Males on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hypogonadal Males is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Top Sponsors

Abbott 1 trials

Named interventions

Most-linked intervention names on Hypogonadal Males records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

ABT-SLV361 Drug
1 trials
Testosterone Gel (FE 999303) Drug
1 trials
placebo Drug
1 trials

US sites by state

Facility locations filed on Hypogonadal Males trials. A trial with sites in several states counts in each.

New York 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hypogonadal Males page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Hypogonadal Males trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Abbott sponsors the most Hypogonadal Males trials on record, review their full trial history before evaluating a specific study. See Abbott's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypogonadal Males condition card totals 2 registered trials; most-linked intervention ABT-SLV361; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.